Stay updated on Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdded 'Small cell lung carcinoma' as a condition term and added a 'Genetic and Rare Diseases Information Center' resource entry.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision on the page updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.2 added and Revision: v3.4.1 removed, indicating a minor platform update that does not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision history updated: added Revision v3.4.1 and removed Revision v3.4.0.SummaryDifference0.0%

- Check92 days agoChange DetectedIntroduces a Show glossary control on the page. Makes minor textual changes to labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data) and updates the revision from v3.3.4 to v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Small Cell Lung Cancer Clinical Trial page.